These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21165704)

  • 41. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treating lipid abnormalities in patients with type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2001 Dec; 88(12A):37N-40N. PubMed ID: 11788129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Managing dyslipidemia in the high-risk patient.
    Stein EA
    Am J Cardiol; 2002 Mar; 89(5A):50C-57C. PubMed ID: 11900720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid lowering and beyond: results from the CARE study on lipoproteins and inflammation. Cholesterol and Recurrent Events.
    Sacks FM; Ridker PM
    Herz; 1999 Feb; 24(1):51-6. PubMed ID: 10093013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesterol and atherosclerosis: a contemporary perspective.
    Kashyap ML
    Ann Acad Med Singap; 1997 Jul; 26(4):517-23. PubMed ID: 9395824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The importance of aggressive lipid management in patients at risk: evidence from recent clinical trials.
    Ferdinand KC
    Clin Cardiol; 2004 Jun; 27(6 Suppl 3):III12-5. PubMed ID: 15239486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipid-modifying therapy in the elderly.
    Hamilton-Craig I; Colquhoun D; Kostner K; Woodhouse S; d'Emden M
    Vasc Health Risk Manag; 2015; 11():251-63. PubMed ID: 25999729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid lowering in high-risk populations: how low should we go?
    Watson K
    Ethn Dis; 2001; 11(4):834-7. PubMed ID: 11763308
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevention of atherosclerosis progression in asymptomatic healthy elderly.
    Lees RS
    Am J Clin Nutr; 2007 Nov; 86(5):1569S-71S. PubMed ID: 17991677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [LDL-cholesterol in secondary prevention: goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)].
    Föger B; Patsch JR
    Wien Klin Wochenschr; 2011 Jan; 123(1-2):21-7. PubMed ID: 21165704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Lowering LDL cholesterol. How much is enough?].
    März W; Grammer TB
    Internist (Berl); 2007 Mar; 48(3):319-26. PubMed ID: 17333056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; ; ;
    Circulation; 2004 Jul; 110(2):227-39. PubMed ID: 15249516
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.